01-17
According to international market researcher Research and Markets, the global regenerative healthcare market is about $8.5 billion in 2020 and will reach $17.9 billion by 2025, with a compound annual market growth rate of 15.9 percent over the next five years.
01-17
-Exosome Industry Research Report
Exosomes easily pass through tiny blood vessels and various pathological cell membranes, and have shown great application potential in disease diagnosis and detection, treatment, drug delivery and other aspects, and become an emerging hot research track in recent years.
01-17
The Stem cell and translational research pilot project is a national key R&D project first established according to the Outline of the National Medium - and Long-Term Program for Scientific and Technological Development (2006-2020) and The State Council's Plan for Deepening the Reform of the Management of Science and Technology Programs (Special Projects, Funds, etc.) Financed by the Central Government. It has eight tasks arranged according to the innovation chain.
01-17
Tianjin Binhai High-tech Zone released the "Encouraging Measures for promoting high-quality development of cell and gene therapy industry" on Oct. 20.
01-17
Recently, the official website of the National Development and Reform Commission issued the "14th Five-Year Plan" biological economy development Plan, and proposed that scientific planning and systematic promotion of the development of biological economy in China is an important direction to adapt to the accelerating evolution of global biotechnology and achieve high level of scientific and technological self-reliance.
01-17
Cutting edge | secrete body outside the industrialization of exploration, and industry outlook
Exosomes have been discovered for nearly 40 years. With the concept of "precision exosomes" proposed in 2015, exosomes have gradually become a research hotspot in disease diagnosis and precision therapy, showing great application prospects.
01-17
According to "Regulations on the Management of Environmental Protection of Construction Projects" (Decree No. 682 of The State Council of the People's Republic of China, implemented on October 01, 2017), "Interim Measures for the Acceptance of Environmental Protection of Construction Projects Completed" (Environmental Assessment [2017] No. 4, Implemented on November 20, 2017), "Pollution Impact Category of Technical Guidelines for Environmental Protection Acceptance of Construction Projects Completed" (Announcement of the Ministry of Ecology and Environment No. 9, 2018, implemented on May 15, 2018), The complete environmental protection acceptance monitoring report of modern medical service platform construction project of Tianjiu Regenerative Medicine (Tianjin) Technology Co., Ltd. based on advanced manufacturing of cell and exosome engineering is now published as follows:
01-17
"Stem cells can reduce inflammation and repair cells, and all the current research on stem cells in COVID-19 treatment will have a huge impact in the future, but it doesn't mean that COVID-19 treatment can't leave them alone,"
01-17
-Summary of domestic stem cell policy in 2020
With the steady development of stem cell research, stem cell technology has shown great potential in the fields of disease treatment, organ transplantation, tissue repair and so on. Our government has also introduced relevant policies and regulations to promote the industrialization of stem cells.